Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results. SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) ...
Leading manufacturer and marketer of proprietary disposable devices, Merit Medical Systems, Inc. MMSI recently announced the receipt of 513(f)(2) (de novo) classification for Embosphere Microspheres ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Merit Medical Systems (South Jordan, UT) received the CE mark to begin offering its Embosphere Microspheres in Europe for relief of symptoms caused by Benign Prostatic Hyperplasia (BPH). An enlarged ...
SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that Embosphere ® Microspheres are now ...
Merit Medical Systems MMSI has secured a major regulatory milestone with the CE Mark approval of its Embosphere Microspheres for genicular artery embolisation (GAE) to treat knee osteoarthritis (OA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results